TD Cowen Maintains Hold on Insulet, Lowers Price Target to $144

Benzinga Newsdesk www.benzinga.com Negative 91.0%

Neg 91% Neu 0% Pos 0%

TD Cowen analyst Mathew Blackman maintains Insulet (NASDAQ:PODD) with a Hold and lowers the price target from $294 to $144.